Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin infusion(CSII) using an insulin pump and insulin therapy using multiple daily injections (MDI) to more closely match physiologic insulin patterns. Type or dosage of insulin can be changed, to meet the individual needs of the patient. Insulin can be packaged in vials (bottles), cartridges or prefilled pens. The cartridges are used with pen injectors whereas the vials are used with syringes.

1. Insulin Delivery Devices Market,by Product Type,by
Distribution Channel,and by Geography-Global Trends,and
Forecast to 2025
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. Preciously, patients
with diabetes had to inject insulin using large glass syringes and reusable needles, both of which
needed sterilization by boiling after each use. Improvements and innovations has led to
development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin
analogs have become available that enable both continuous subcutaneous insulin infusion (CSII)
using an insulin pump and insulin therapy using multiple daily injections (MDI) to more closely
match physiologic insulin patterns. Type or dosage of insulin can be changed, to meet the
individual needs of the patient. Insulin can be packaged in vials (bottles), cartridges or prefilled
pens. The cartridges are used with pen injectors whereas the vials are used with syringes.
The global insulin delivery devices market was valued at US$ 11,326.9 million in 2017 and is
expected to witness a CAGR of 11.3% over the forecast period (2017–2025).
Get PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1352
Increasing prevalence of diabetes is expected to drive growth of the global insulin delivery devices
market over the forecast period

2. Increasing prevalence and incidence of diabetes is a major factor driving the global insulin
delivery devices market growth. According to the Centers for Disease Control and Prevention
(CDC), 2014, around 29.1 million people in the U.S. have diabetes with a healthcare burden of
around US$ 245 Bn and with an estimated 4.6–9.2% of pregnant women affected by gestational
diabetes. Moreover, the Australian government launched National Diabetes Strategy (2016–2020), to
prevent diabetes and support people living with diabetes. Thus, increasing government initiatives to
support diabetic patients is expected to favor growth of the global insulin delivery devices market.
Development of systems and devices for improved drug delivery is expected to drive growth of
the market. When compared with vial and syringe regimens, insulin pens offer a greater clinical
efficacy, improved quality of life, and increased dosing accuracy, particularly at low doses. Thus,
introduction of insulin pen devices has aided patients with diabetes mellitus in easier and more
convenient treatment regimens. For instance, in January 2014, Novo Nordisk launched the NovoPen
Echo in the U.S. market. This is the first and only pen device available in the U.S. with half-
unit dosing and a memory function that can record the dose and time passed since the last
injection.
Increasing adoption of advanced devices for insulin delivery is driving growth of the market
Increasing awareness among population regarding insulin delivery devices coupled with high
demand for insulin administration for diabetes control are expected to drive growth of the market.
Among regions, in 2017, North America, accounted for largest share in global insulin delivery
devices market, followed by Europe, owing to high prevalence of lifestyle associated diseases,
implementation of awareness programs regarding diabetes, and high adoption of advanced medical
devices. For instance, in 2010, according to Journal of Diabetes Science and Technology, majorly
insulin pumps were used on the American side of the Atlantic than on the European side, which
is projected to propel demand for insulin pumps over the forecast period.
Furthermore, in 2016, the UAE Ministry of Health and Prevention in partnership with the Emirates
Diabetes Society and Ministry with AstraZeneca Gulf, launched Circle of Care, an education and
support program, which intends to improve the well-being of people in the UAE suffering from or

3. at risk of developing type 2 diabetes, in turn fueling growth of the market over the forecast
period.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing the
most precise market analysis. The company leverages a data triangulation model which helps
company to gauge the market dynamics and provide accurate estimates. Key components of the
research methodologies followed for all our market reports include:
• Primary Research (Trade Surveys and Experts Interviews)
• Desk Research
• Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and
global reputed paid data bases, which helps the company to figure out the regional and global
market trends and dynamics. The company analyses the industry from the 360 Degree Perspective
i.e. from the Supply Side and Demand Side which enables us to provide granular details of the
entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is
followed to arrive at ultimate research findings.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1352
Key players in the market are focusing on developing next generation devices to remain
competitive, while seeking ways to enhance their design capabilities. For instance, in October
2017, Eli Lilly and Company announced its plans to invest US$ 72 million in an insulin
manufacturing project at one of its Indianapolis, U.S. facilities. The investment will be used to
replace an existing insulin vial filling line and allow the company to meet growing demand for its

4. insulin - including Humalog (insulin lispro) and Humulin (human insulin) - while upgrading to
state-of-the-art technology and preparing for its insulin pipeline.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com